Compare BWAY & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWAY | MCI |
|---|---|---|
| Founded | 2003 | 1971 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.8M | 362.0M |
| IPO Year | N/A | N/A |
| Metric | BWAY | MCI |
|---|---|---|
| Price | $15.64 | $17.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.25 | N/A |
| AVG Volume (30 Days) | ★ 167.5K | 57.3K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.82 |
| Revenue | N/A | N/A |
| Revenue This Year | $309.69 | N/A |
| Revenue Next Year | $26.21 | N/A |
| P/E Ratio | $81.98 | ★ $9.81 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.84 | $17.24 |
| 52 Week High | $26.63 | $23.00 |
| Indicator | BWAY | MCI |
|---|---|---|
| Relative Strength Index (RSI) | 56.30 | 39.21 |
| Support Level | $14.56 | $17.24 |
| Resistance Level | $16.63 | $18.19 |
| Average True Range (ATR) | 0.75 | 0.58 |
| MACD | 0.56 | 0.05 |
| Stochastic Oscillator | 88.21 | 33.33 |
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.